Vertex Pharmaceuticals

VRTX

84 Followers

$429.60

-1.20%

-$5.22

7 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

VRTX Fair Price

$727.76

Overvalued by 87.8%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Vertex Pharmaceuticals (VRTX) is a leading biopharmaceutical company specializing in the development of drugs for the treatment of rare and severe diseases. Their primary focus is on the development of innovative therapies for patients with cystic fibrosis, a genetic disorder affecting the respiratory and digestive systems. Vertex Pharmaceuticals is at the forefront of gene therapy and molecular-based treatments. Vertex Pharmaceuticals stock is suitable for investors interested in the pharmaceutical sector and investments in the treatment of rare diseases. Add Vertex Pharmaceuticals stock to your watchlist on Bulios and be the first to receive updates on new medical breakthroughs and the development of therapies from this prominent company.